- or is it the other way around?
Donald Kennedy.
Dec 13, 2000
LONDON Craig Venter's Celera Genomics is never afraid to court controversy, and a new agreement with the US journal
Ownership and control of intellectual property is the issue.
LONDON Craig Venter's Celera Genomics is never afraid to court controversy, and a new agreement with the US journal
Ownership and control of intellectual property is the issue.